- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Telehealth Intervention Improved QoL Among Head and Neck Cancer Patients
A telehealth intervention experiment in head and neck cancer patients was found to relive some posttreatment distress symptoms.
A randomized clinical trial in head or neck cancer patients evaluated the imact of telehealth intervention in reducing the symptoms of distress and on their overall quality of life (QoL), during the acute phase of their treatment.
The trial was conducted with 80 patients (45 treatment, 35 control) who had been diagnosed with head or neck cancer and were receiving 1 or more treatment modalities.
i
Treatment group participants responded daily to symptom management algorithms using a simple telehealth messaging device. The authors conclude that they did observe
mprovement in some aspects of posttreatment QoL and symptom burden.
Read the complete paper in The Journal of Community and Supportive Oncology.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
